Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXB7
|
ENSG00000260027.3 | homeobox B7 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_46689262_46689416 | HOXB7 | 960 | 0.261812 | -0.46 | 2.1e-01 | Click! |
chr17_46687714_46688061 | HOXB7 | 492 | 0.546515 | 0.32 | 4.1e-01 | Click! |
chr17_46688135_46688867 | HOXB7 | 122 | 0.888783 | -0.14 | 7.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_182992678_182993398 | 1.79 |
B3GNT5 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
9906 |
0.2 |
chr9_137443475_137443828 | 1.60 |
COL5A1 |
collagen, type V, alpha 1 |
89969 |
0.08 |
chr1_85755499_85756121 | 1.51 |
ENSG00000264380 |
. |
5517 |
0.15 |
chr9_79075654_79076239 | 1.31 |
GCNT1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
1800 |
0.46 |
chr9_97567295_97567893 | 1.30 |
ENSG00000252153 |
. |
4650 |
0.2 |
chr10_10834102_10834253 | 1.21 |
CELF2 |
CUGBP, Elav-like family member 2 |
213082 |
0.02 |
chr2_217354341_217354722 | 1.18 |
AC098820.4 |
|
2612 |
0.22 |
chr12_1427689_1428011 | 1.15 |
RP5-951N9.2 |
|
67149 |
0.11 |
chr1_15504056_15504331 | 1.13 |
C1orf195 |
chromosome 1 open reading frame 195 |
6380 |
0.22 |
chr21_40683413_40684326 | 1.11 |
BRWD1 |
bromodomain and WD repeat domain containing 1 |
1627 |
0.24 |
chr1_67397953_67399117 | 1.11 |
MIER1 |
mesoderm induction early response 1, transcriptional regulator |
2609 |
0.29 |
chr10_77307515_77307943 | 1.10 |
ENSG00000207583 |
. |
4487 |
0.3 |
chr2_43242041_43242192 | 1.04 |
ENSG00000207087 |
. |
76516 |
0.11 |
chr6_37210819_37210970 | 1.03 |
ENSG00000238375 |
. |
8188 |
0.16 |
chr2_3625268_3626011 | 1.00 |
ENSG00000252531 |
. |
2521 |
0.16 |
chr1_168090235_168090525 | 0.99 |
GPR161 |
G protein-coupled receptor 161 |
15241 |
0.22 |
chr8_97936602_97936965 | 0.95 |
CPQ |
carboxypeptidase Q |
104914 |
0.08 |
chr14_77463878_77464029 | 0.95 |
ENSG00000266553 |
. |
29845 |
0.15 |
chrX_133681354_133681505 | 0.93 |
ENSG00000223749 |
. |
688 |
0.44 |
chr17_67498171_67498584 | 0.93 |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
30 |
0.99 |
chr8_129186357_129186538 | 0.92 |
ENSG00000221261 |
. |
24085 |
0.22 |
chr11_36035998_36036518 | 0.89 |
ENSG00000263389 |
. |
4610 |
0.26 |
chr1_93971516_93971910 | 0.88 |
ENSG00000212601 |
. |
17704 |
0.18 |
chr11_12714787_12714938 | 0.87 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
17812 |
0.26 |
chr20_1450275_1450457 | 0.87 |
NSFL1C |
NSFL1 (p97) cofactor (p47) |
1949 |
0.26 |
chr4_86954647_86954929 | 0.87 |
RP13-514E23.1 |
|
19761 |
0.19 |
chr1_59629351_59629568 | 0.87 |
FGGY |
FGGY carbohydrate kinase domain containing |
132851 |
0.06 |
chr12_95510407_95510956 | 0.86 |
FGD6 |
FYVE, RhoGEF and PH domain containing 6 |
68 |
0.98 |
chr11_32078115_32078502 | 0.86 |
RP1-17K7.3 |
|
3502 |
0.18 |
chr3_188995375_188995558 | 0.86 |
TPRG1-AS2 |
TPRG1 antisense RNA 2 |
37083 |
0.21 |
chr20_48293517_48294318 | 0.85 |
B4GALT5 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 |
36498 |
0.15 |
chr12_26428456_26429005 | 0.85 |
RP11-283G6.5 |
|
3877 |
0.25 |
chr2_175461673_175462147 | 0.84 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
583 |
0.74 |
chr18_8049341_8049492 | 0.84 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
36284 |
0.18 |
chr2_47075547_47075844 | 0.84 |
AC016722.3 |
|
4940 |
0.18 |
chr12_109234336_109234487 | 0.83 |
ENSG00000207622 |
. |
3629 |
0.19 |
chr7_84765663_84765814 | 0.82 |
SEMA3D |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
14487 |
0.32 |
chr3_132255311_132255511 | 0.82 |
ACKR4 |
atypical chemokine receptor 4 |
60670 |
0.13 |
chr6_22026198_22026944 | 0.82 |
ENSG00000222515 |
. |
59202 |
0.17 |
chr13_31747131_31747282 | 0.80 |
HSPH1 |
heat shock 105kDa/110kDa protein 1 |
10681 |
0.25 |
chr21_42513522_42513800 | 0.80 |
LINC00323 |
long intergenic non-protein coding RNA 323 |
5689 |
0.18 |
chr3_149865923_149866214 | 0.80 |
RP11-167H9.4 |
|
50249 |
0.14 |
chr1_214688298_214688531 | 0.79 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
36152 |
0.21 |
chr13_45769539_45769983 | 0.79 |
KCTD4 |
potassium channel tetramerization domain containing 4 |
909 |
0.6 |
chr8_143757168_143757384 | 0.79 |
PSCA |
prostate stem cell antigen |
4598 |
0.13 |
chr4_169555148_169555325 | 0.79 |
PALLD |
palladin, cytoskeletal associated protein |
2468 |
0.31 |
chr7_116211652_116211947 | 0.79 |
AC006159.4 |
|
511 |
0.78 |
chr8_108715935_108716182 | 0.78 |
ENSG00000200806 |
. |
180664 |
0.03 |
chr12_66271805_66272278 | 0.77 |
RP11-366L20.2 |
Uncharacterized protein |
3317 |
0.24 |
chr11_12204461_12204638 | 0.77 |
MICAL2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
20846 |
0.23 |
chr13_109567579_109568598 | 0.77 |
MYO16 |
myosin XVI |
29571 |
0.26 |
chr21_36309854_36310535 | 0.77 |
RUNX1 |
runt-related transcription factor 1 |
48107 |
0.19 |
chr7_66313185_66313446 | 0.76 |
GTF2IRD1P1 |
GTF2I repeat domain containing 1 pseusogene 1 |
15302 |
0.17 |
chr3_47203435_47204414 | 0.76 |
SETD2 |
SET domain containing 2 |
1142 |
0.44 |
chr2_161232105_161232912 | 0.75 |
ENSG00000252465 |
. |
20971 |
0.19 |
chr18_57568296_57569123 | 0.75 |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
1461 |
0.52 |
chr10_36198990_36199141 | 0.75 |
FZD8 |
frizzled family receptor 8 |
268703 |
0.02 |
chr5_61573173_61573324 | 0.75 |
KIF2A |
kinesin heavy chain member 2A |
28741 |
0.23 |
chr2_235599820_235600211 | 0.75 |
ARL4C |
ADP-ribosylation factor-like 4C |
194318 |
0.03 |
chr2_201272430_201272581 | 0.75 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
14705 |
0.18 |
chr1_89164172_89164598 | 0.74 |
RP11-76N22.2 |
|
13498 |
0.22 |
chr15_52138768_52139605 | 0.74 |
TMOD3 |
tropomodulin 3 (ubiquitous) |
15849 |
0.15 |
chr18_9869607_9869758 | 0.74 |
TXNDC2 |
thioredoxin domain containing 2 (spermatozoa) |
16081 |
0.16 |
chr11_67979238_67979938 | 0.74 |
SUV420H1 |
suppressor of variegation 4-20 homolog 1 (Drosophila) |
633 |
0.74 |
chr1_23609794_23609945 | 0.74 |
HNRNPR |
heterogeneous nuclear ribonucleoprotein R |
60886 |
0.08 |
chr12_78242226_78242377 | 0.74 |
NAV3 |
neuron navigator 3 |
17232 |
0.3 |
chr2_196440572_196441282 | 0.74 |
SLC39A10 |
solute carrier family 39 (zinc transporter), member 10 |
226 |
0.96 |
chr7_17410528_17410788 | 0.74 |
ENSG00000199473 |
. |
2292 |
0.4 |
chr3_60921706_60921857 | 0.73 |
ENSG00000212211 |
. |
79504 |
0.12 |
chr15_57129370_57129631 | 0.73 |
ZNF280D |
zinc finger protein 280D |
81269 |
0.1 |
chr5_150171379_150171530 | 0.73 |
AC010441.1 |
|
13587 |
0.15 |
chr12_98869370_98869670 | 0.72 |
RP11-181C3.1 |
Uncharacterized protein |
28113 |
0.14 |
chr7_115980158_115980451 | 0.72 |
ENSG00000216076 |
. |
5694 |
0.22 |
chr3_177651530_177651798 | 0.72 |
ENSG00000199858 |
. |
73903 |
0.13 |
chr5_75966499_75966843 | 0.72 |
F2R |
coagulation factor II (thrombin) receptor |
45197 |
0.11 |
chr6_7699188_7699339 | 0.72 |
BMP6 |
bone morphogenetic protein 6 |
27767 |
0.23 |
chr20_46093707_46094007 | 0.71 |
ENSG00000202186 |
. |
19268 |
0.16 |
chr5_71807491_71807707 | 0.71 |
ZNF366 |
zinc finger protein 366 |
4045 |
0.32 |
chr6_147234613_147234825 | 0.71 |
STXBP5-AS1 |
STXBP5 antisense RNA 1 |
1977 |
0.49 |
chr3_188599582_188599733 | 0.71 |
TPRG1 |
tumor protein p63 regulated 1 |
65346 |
0.14 |
chr13_97959313_97959591 | 0.71 |
MBNL2 |
muscleblind-like splicing regulator 2 |
30994 |
0.21 |
chr9_127520364_127520515 | 0.71 |
RP11-175D17.3 |
|
11963 |
0.14 |
chr2_193011022_193011173 | 0.70 |
TMEFF2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
48153 |
0.19 |
chr13_32691390_32691679 | 0.70 |
FRY |
furry homolog (Drosophila) |
56533 |
0.14 |
chr5_135347344_135347609 | 0.70 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
17108 |
0.2 |
chr1_200142035_200142186 | 0.70 |
ENSG00000221403 |
. |
28148 |
0.23 |
chr1_206846612_206846999 | 0.70 |
ENSG00000252853 |
. |
8503 |
0.14 |
chr3_18140205_18140557 | 0.70 |
RP11-158G18.1 |
|
310746 |
0.01 |
chr20_17539948_17540099 | 0.69 |
BFSP1 |
beaded filament structural protein 1, filensin |
418 |
0.84 |
chr14_78066923_78067218 | 0.69 |
SPTLC2 |
serine palmitoyltransferase, long chain base subunit 2 |
3406 |
0.24 |
chr10_36110915_36111066 | 0.69 |
FZD8 |
frizzled family receptor 8 |
180628 |
0.03 |
chr12_13278087_13278467 | 0.69 |
GSG1 |
germ cell associated 1 |
21658 |
0.19 |
chr12_124865349_124865540 | 0.69 |
NCOR2 |
nuclear receptor corepressor 2 |
7926 |
0.29 |
chr5_17235667_17236039 | 0.68 |
ENSG00000252908 |
. |
4867 |
0.21 |
chr15_68712890_68713041 | 0.68 |
ITGA11 |
integrin, alpha 11 |
11527 |
0.27 |
chr1_234700121_234700537 | 0.68 |
ENSG00000212144 |
. |
28692 |
0.16 |
chr1_95009721_95009872 | 0.68 |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
2440 |
0.41 |
chr11_94483644_94484054 | 0.68 |
RP11-867G2.8 |
|
10328 |
0.22 |
chr15_35598050_35598318 | 0.67 |
ENSG00000265102 |
. |
66381 |
0.14 |
chr6_34318041_34318401 | 0.67 |
NUDT3 |
nudix (nucleoside diphosphate linked moiety X)-type motif 3 |
42230 |
0.14 |
chr12_11733022_11733284 | 0.67 |
ENSG00000251747 |
. |
33740 |
0.16 |
chr5_65441904_65442539 | 0.67 |
SREK1 |
splicing regulatory glutamine/lysine-rich protein 1 |
1558 |
0.34 |
chr6_155005041_155005297 | 0.67 |
SCAF8 |
SR-related CTD-associated factor 8 |
49290 |
0.17 |
chr1_218524106_218524737 | 0.67 |
TGFB2 |
transforming growth factor, beta 2 |
4844 |
0.24 |
chr9_124126029_124126317 | 0.67 |
STOM |
stomatin |
6310 |
0.16 |
chr11_75657287_75657506 | 0.67 |
ENSG00000223013 |
. |
11416 |
0.16 |
chr2_223907840_223908197 | 0.66 |
KCNE4 |
potassium voltage-gated channel, Isk-related family, member 4 |
8514 |
0.28 |
chr1_240264656_240264807 | 0.66 |
FMN2 |
formin 2 |
9551 |
0.25 |
chr7_92645118_92645650 | 0.66 |
ENSG00000266794 |
. |
44771 |
0.17 |
chr8_24206460_24207135 | 0.66 |
ADAM28 |
ADAM metallopeptidase domain 28 |
7632 |
0.22 |
chr2_235933311_235933462 | 0.66 |
SH3BP4 |
SH3-domain binding protein 4 |
29902 |
0.26 |
chr3_151581991_151582142 | 0.66 |
SUCNR1 |
succinate receptor 1 |
9365 |
0.23 |
chr2_26981757_26981908 | 0.66 |
SLC35F6 |
solute carrier family 35, member F6 |
5324 |
0.2 |
chr10_3792550_3792786 | 0.66 |
RP11-184A2.3 |
|
591 |
0.78 |
chr6_89744917_89745362 | 0.66 |
ENSG00000223001 |
. |
28270 |
0.13 |
chr18_21207750_21207901 | 0.66 |
ANKRD29 |
ankyrin repeat domain 29 |
21661 |
0.17 |
chr14_59749878_59750029 | 0.65 |
DAAM1 |
dishevelled associated activator of morphogenesis 1 |
19780 |
0.26 |
chr6_159128544_159128695 | 0.65 |
SYTL3 |
synaptotagmin-like 3 |
44424 |
0.13 |
chr9_35522536_35522687 | 0.65 |
RUSC2 |
RUN and SH3 domain containing 2 |
16018 |
0.14 |
chr17_26221487_26221715 | 0.65 |
LYRM9 |
LYR motif containing 9 |
1192 |
0.33 |
chr3_185479152_185479525 | 0.65 |
ENSG00000265470 |
. |
6354 |
0.24 |
chr17_74734284_74735284 | 0.65 |
MFSD11 |
major facilitator superfamily domain containing 11 |
631 |
0.43 |
chr12_12813557_12813849 | 0.65 |
GPR19 |
G protein-coupled receptor 19 |
23752 |
0.15 |
chr2_43686300_43686580 | 0.65 |
ENSG00000252804 |
. |
50994 |
0.16 |
chr7_98047722_98048054 | 0.64 |
BAIAP2L1 |
BAI1-associated protein 2-like 1 |
17508 |
0.24 |
chr1_40358181_40358689 | 0.64 |
RP1-118J21.5 |
|
4982 |
0.14 |
chr5_40258873_40259248 | 0.64 |
ENSG00000199361 |
. |
10600 |
0.28 |
chr4_123686417_123686718 | 0.64 |
BBS12 |
Bardet-Biedl syndrome 12 |
32615 |
0.17 |
chr20_10286775_10287859 | 0.64 |
ENSG00000211588 |
. |
55561 |
0.13 |
chr8_128755138_128755289 | 0.64 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
6736 |
0.28 |
chr3_15834561_15835314 | 0.64 |
ANKRD28 |
ankyrin repeat domain 28 |
3091 |
0.28 |
chr13_24462234_24462908 | 0.64 |
C1QTNF9B-AS1 |
C1QTNF9B antisense RNA 1 |
457 |
0.68 |
chr6_143592394_143592545 | 0.64 |
AIG1 |
androgen-induced 1 |
145082 |
0.04 |
chr13_31774982_31775836 | 0.64 |
B3GALTL |
beta 1,3-galactosyltransferase-like |
1336 |
0.55 |
chr2_119495850_119496001 | 0.64 |
EN1 |
engrailed homeobox 1 |
109329 |
0.07 |
chr4_114706244_114706541 | 0.64 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
23309 |
0.27 |
chr8_135840717_135840868 | 0.64 |
ENSG00000199153 |
. |
23604 |
0.22 |
chr14_102537656_102538063 | 0.64 |
RP11-1017G21.4 |
|
5294 |
0.17 |
chr10_127859322_127859597 | 0.63 |
ENSG00000222740 |
. |
25308 |
0.25 |
chr7_46792365_46792593 | 0.63 |
AC011294.3 |
Uncharacterized protein |
55759 |
0.18 |
chr2_64881941_64882849 | 0.63 |
SERTAD2 |
SERTA domain containing 2 |
1348 |
0.52 |
chr5_123932447_123932800 | 0.63 |
RP11-436H11.2 |
|
131901 |
0.05 |
chr7_41734895_41735186 | 0.63 |
INHBA-AS1 |
INHBA antisense RNA 1 |
1494 |
0.42 |
chr3_171528829_171529427 | 0.63 |
PLD1 |
phospholipase D1, phosphatidylcholine-specific |
844 |
0.52 |
chr5_114930797_114930948 | 0.63 |
AC010226.4 |
|
6882 |
0.17 |
chr10_114746306_114746664 | 0.63 |
RP11-57H14.2 |
|
34851 |
0.18 |
chr9_127471212_127471497 | 0.63 |
ENSG00000207737 |
. |
15365 |
0.14 |
chr12_65960554_65960705 | 0.63 |
MSRB3 |
methionine sulfoxide reductase B3 |
239974 |
0.02 |
chr3_65938063_65938214 | 0.63 |
MAGI1-IT1 |
MAGI1 intronic transcript 1 (non-protein coding) |
2095 |
0.32 |
chr4_109967763_109967914 | 0.63 |
COL25A1 |
collagen, type XXV, alpha 1 |
222463 |
0.02 |
chr13_45737350_45737501 | 0.63 |
ENSG00000252055 |
. |
25325 |
0.14 |
chr1_206846136_206846472 | 0.63 |
ENSG00000252853 |
. |
9004 |
0.14 |
chr7_101524016_101524398 | 0.62 |
CTA-339C12.1 |
|
56198 |
0.12 |
chr13_45912749_45913694 | 0.62 |
TPT1 |
tumor protein, translationally-controlled 1 |
447 |
0.57 |
chr1_84366680_84366831 | 0.62 |
TTLL7-IT1 |
TTLL7 intronic transcript 1 (non-protein coding) |
83228 |
0.09 |
chr1_25666704_25667414 | 0.62 |
ENSG00000252515 |
. |
403 |
0.75 |
chr15_99881817_99881968 | 0.62 |
AC022819.2 |
Uncharacterized protein |
22064 |
0.18 |
chr17_18478085_18478236 | 0.62 |
ENSG00000264948 |
. |
30509 |
0.11 |
chr2_113542490_113542945 | 0.62 |
IL1A |
interleukin 1, alpha |
550 |
0.75 |
chr1_201562210_201562568 | 0.62 |
AC096677.1 |
Uncharacterized protein ENSP00000471857 |
29624 |
0.14 |
chr7_77496191_77496692 | 0.62 |
PHTF2 |
putative homeodomain transcription factor 2 |
26944 |
0.18 |
chr9_112955106_112955494 | 0.62 |
C9orf152 |
chromosome 9 open reading frame 152 |
15169 |
0.23 |
chr14_50335281_50335979 | 0.62 |
ENSG00000265150 |
. |
6063 |
0.11 |
chr22_40906008_40906449 | 0.61 |
RP4-591N18.2 |
|
11576 |
0.17 |
chr1_172255657_172255977 | 0.61 |
ENSG00000252354 |
. |
61466 |
0.11 |
chr9_14281034_14281328 | 0.61 |
NFIB |
nuclear factor I/B |
26831 |
0.22 |
chr8_125902826_125902977 | 0.61 |
ENSG00000263735 |
. |
68601 |
0.1 |
chr12_52348007_52348213 | 0.61 |
ACVR1B |
activin A receptor, type IB |
946 |
0.5 |
chr21_27762100_27762398 | 0.61 |
AP001596.6 |
|
206 |
0.95 |
chr7_27141979_27142469 | 0.61 |
HOXA2 |
homeobox A2 |
206 |
0.84 |
chr9_85627503_85627751 | 0.61 |
RASEF |
RAS and EF-hand domain containing |
50416 |
0.18 |
chr4_169526190_169526341 | 0.61 |
PALLD |
palladin, cytoskeletal associated protein |
26501 |
0.19 |
chr5_52630256_52630554 | 0.60 |
FST |
follistatin |
145834 |
0.04 |
chr10_63734512_63734894 | 0.60 |
ENSG00000221272 |
. |
47926 |
0.17 |
chr5_58675874_58676025 | 0.60 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
23148 |
0.28 |
chr4_108775118_108775299 | 0.60 |
ENSG00000222691 |
. |
13858 |
0.19 |
chr8_104154978_104155229 | 0.60 |
C8orf56 |
chromosome 8 open reading frame 56 |
1400 |
0.28 |
chr11_95995991_95996601 | 0.60 |
ENSG00000266192 |
. |
78306 |
0.1 |
chr12_54652947_54653855 | 0.60 |
CBX5 |
chromobox homolog 5 |
25 |
0.94 |
chr14_81769226_81769438 | 0.60 |
STON2 |
stonin 2 |
26055 |
0.23 |
chr3_185646631_185647450 | 0.60 |
TRA2B |
transformer 2 beta homolog (Drosophila) |
5359 |
0.23 |
chr2_214028736_214028887 | 0.60 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
11660 |
0.3 |
chr1_192136845_192136996 | 0.60 |
RGS18 |
regulator of G-protein signaling 18 |
9333 |
0.32 |
chr12_66223292_66223675 | 0.60 |
HMGA2 |
high mobility group AT-hook 2 |
4580 |
0.24 |
chr1_14870206_14870357 | 0.60 |
KAZN |
kazrin, periplakin interacting protein |
54919 |
0.18 |
chr6_44202734_44202885 | 0.60 |
SLC29A1 |
solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
7933 |
0.11 |
chr8_119778762_119778913 | 0.60 |
SAMD12 |
sterile alpha motif domain containing 12 |
144603 |
0.05 |
chr1_234998930_234999119 | 0.60 |
ENSG00000201638 |
. |
25304 |
0.21 |
chr3_8978587_8978738 | 0.60 |
ENSG00000199815 |
. |
5483 |
0.23 |
chr1_60164517_60164668 | 0.60 |
ENSG00000266150 |
. |
34376 |
0.21 |
chr20_52273322_52273781 | 0.60 |
ENSG00000238468 |
. |
11746 |
0.23 |
chr16_72289972_72290233 | 0.60 |
PMFBP1 |
polyamine modulated factor 1 binding protein 1 |
79325 |
0.09 |
chr17_45302408_45302765 | 0.60 |
ENSG00000252088 |
. |
4578 |
0.14 |
chr8_16489448_16489933 | 0.59 |
MSR1 |
macrophage scavenger receptor 1 |
64819 |
0.15 |
chr7_107670861_107671012 | 0.59 |
ENSG00000216085 |
. |
6445 |
0.18 |
chr16_55576875_55577026 | 0.59 |
LPCAT2 |
lysophosphatidylcholine acyltransferase 2 |
14545 |
0.2 |
chr3_197036148_197036299 | 0.59 |
DLG1 |
discs, large homolog 1 (Drosophila) |
10052 |
0.16 |
chr6_139690937_139691976 | 0.59 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
3894 |
0.32 |
chr15_70928689_70929028 | 0.59 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
65762 |
0.13 |
chr8_130692569_130692862 | 0.59 |
GSDMC |
gasdermin C |
106419 |
0.06 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 2.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.3 | 1.8 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.3 | 0.9 | GO:0010193 | response to ozone(GO:0010193) |
0.3 | 0.8 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.3 | 1.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.1 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 0.8 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 1.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.7 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.2 | 0.4 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.2 | 1.2 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.2 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.8 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.5 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.2 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.2 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.7 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 1.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.6 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.5 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.4 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.5 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.1 | 0.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.5 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.1 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.4 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.5 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.5 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.3 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.9 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.4 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.7 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.9 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.3 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.6 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.1 | 0.4 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.4 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.9 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.3 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.3 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.4 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.1 | 0.2 | GO:0060044 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:0042520 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.1 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 1.9 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.5 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.5 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.1 | 0.2 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.4 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.2 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.2 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.4 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.3 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.6 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.3 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.2 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.1 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 1.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.5 | GO:0060840 | artery morphogenesis(GO:0048844) artery development(GO:0060840) |
0.1 | 0.2 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.2 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.1 | 0.2 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) regulation of membrane lipid distribution(GO:0097035) |
0.1 | 1.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.1 | 0.1 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0072070 | loop of Henle development(GO:0072070) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.3 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.2 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.1 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.4 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.1 | 0.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.2 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.7 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.3 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.0 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) isoleucine metabolic process(GO:0006549) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.0 | 0.2 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.5 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.1 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.2 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.7 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0036315 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.0 | 0.6 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.0 | 0.0 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.6 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.3 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0071071 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) regulation of phospholipid biosynthetic process(GO:0071071) |
0.0 | 0.0 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.0 | 0.0 | GO:0060119 | inner ear receptor cell development(GO:0060119) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 1.3 | GO:0060606 | tube closure(GO:0060606) |
0.0 | 0.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.2 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.0 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.1 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.3 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.0 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.7 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.0 | 0.0 | GO:0060872 | semicircular canal development(GO:0060872) |
0.0 | 0.3 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.1 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:1903019 | negative regulation of glycoprotein biosynthetic process(GO:0010561) negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.3 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.2 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.2 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0003170 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.0 | 0.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.0 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 1.0 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.0 | 0.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.2 | GO:0036294 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.0 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.5 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.3 | GO:0010510 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.2 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0048820 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.0 | 0.2 | GO:0001841 | neural tube formation(GO:0001841) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.1 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0098764 | meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.3 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.0 | 0.0 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.2 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.0 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.0 | GO:0006837 | serotonin transport(GO:0006837) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.0 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.2 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.0 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.0 | 0.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.0 | GO:0039703 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.0 | 0.1 | GO:0043558 | regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.2 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.0 | 0.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.0 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) negative regulation of epidermis development(GO:0045683) |
0.0 | 0.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.0 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0031281 | positive regulation of cyclase activity(GO:0031281) positive regulation of adenylate cyclase activity(GO:0045762) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.0 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.2 | GO:0009251 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.0 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.0 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 1.7 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.0 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.0 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:0003097 | renal water transport(GO:0003097) |
0.0 | 0.3 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.2 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:0015851 | nucleobase transport(GO:0015851) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 0.5 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.4 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.8 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 1.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 0.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.6 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.1 | 0.4 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.2 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 2.0 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.3 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.2 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 2.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 1.0 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 1.5 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 1.3 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 8.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.1 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 1.2 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.2 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.2 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 1.2 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 1.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 1.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 1.3 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.0 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.3 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 2.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 1.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.5 | 1.5 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.4 | 1.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 0.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 1.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.7 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.8 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.8 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 1.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.5 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.1 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.1 | 0.3 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.1 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 1.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 1.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.2 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.8 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0004340 | glucokinase activity(GO:0004340) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 1.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.2 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 3.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.7 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 1.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.2 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 1.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.2 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.2 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 1.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 1.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.2 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.7 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 2.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 1.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.2 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.7 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 2.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 5.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 6.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 3.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.2 | 2.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 2.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 3.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.7 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 1.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.5 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.0 | 0.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |